BioCryst Pharmaceuticals
BCRX
#4635
Rank
โ‚น206.02 B
Marketcap
โ‚น821.47
Share price
-2.77%
Change (1 day)
22.86%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): โ‚น23.96 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น0.87 Billion. , an increase over its 2024 earnings that were of -โ‚น8.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น25.07 B-407.51%
2024 -โ‚น8.16 Billion-61.56%
2023 -โ‚น21.22 Billion-7.43%
2022 -โ‚น22.92 Billion34.42%
2021 -โ‚น17.05 Billion-0.55%
2020 -โ‚น17.15 Billion67.88%
2019 -โ‚น10.22 Billion7.55%
2018 -โ‚น9.5 Billion53.92%
2017 -โ‚น6.17 Billion19.29%
2016 -โ‚น5.18 Billion28.19%
2015 -โ‚น4.04 Billion-4.8%
2014 -โ‚น4.24 Billion50.09%
2013 -โ‚น2.83 Billion-23.29%
2012 -โ‚น3.69 Billion-26.19%
2011 -โ‚น4.99 Billion54.78%
2010 -โ‚น3.23 Billion150.1%
2009 -โ‚น1.29 Billion-49.43%
2008 -โ‚น2.55 Billion14.07%
2007 -โ‚น2.24 Billion-49.31%
2006 -โ‚น4.41 Billion72.87%
2005 -โ‚น2.55 Billion22.08%
2004 -โ‚น2.09 Billion75.3%
2003 -โ‚น1.2 Billion-25.36%
2002 -โ‚น1.6 Billion225.05%
2001 -โ‚น0.5 Billion-56.6%
2000 -โ‚น1.14 Billion50.63%
1999 -โ‚น0.76 Billion38.05%
1998 -โ‚น0.55 Billion-52.46%
1997 -โ‚น1.15 Billion58.44%
1996 -โ‚น0.73 Billion-14.44%
1995 -โ‚น0.85 Billion28.57%
1994 -โ‚น0.66 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚น918.71 B 3,563.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น927.97 B 3,600.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚น23.65 Billion-194.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น7.86 B-68.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น35.16 B 40.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น26.95 Billion-207.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚น0.77 Billion-103.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น2.33 Billion-109.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น15.50 B-38.18%๐Ÿ‡บ๐Ÿ‡ธ USA